title: Remifentanil: an update.
abstract: OBJECTIVE
  Remifentanil has now reached maturity, as reflected by the increasing number of clinical papers relating to its use. Its position among anaesthetic drugs is now better understood, and this review will attempt to place it in the context of current clinical practice.
  Propofol reduces the initial distribution of remifentanil, leading to higher concentrations during induction. Propofol and remifentanil administered together at sedative doses display a major synergistic interaction on the respiratory drive. Remifentanil accelerates the penetration of sevoflurane to its site of effect. The risk of intraoperative awareness seems to be low when remifentanil is associated to very low concentrations of hypnotic drugs, but this field warrants further investigation. Acute tolerance to opioids and its prevention remain controversial.
  
  
  CONCLUSIONS
  Remifentanil is the opioid of choice for tracheal intubation without muscle relaxants. It provides an alternative to regional anaesthesia in labour pain control. Target-controlled infusion may further improve the administration of remifentanil.
authors.affiliation: Service d'Anesthésie-Réanimation, Hôpital Bichat, Paris, France. frederique.servin@bch.ap-hop-paris.fr
authors.forename: Frédérique S
authors.initials: FS
authors.lastname: Servin